Skip to content

Nationwide adoption: Osteopore deploys 3D printing across Singapore hospitals

Share this article

LinkedInFacebookXWhatsAppE-mail

Osteopore's 3D scaffold tissue
Osteopore's 3-D scaffold tissue. Credit: Osteopore

When you know that by this time last year, Osteopore’s 3D printed implants were added to Singapore’s Ministry of Health’s subsidy list, it’s not surprising to see how the company is now expanding clinical 3D printing services across Singapore’s healthcare system.

This expansion strengthens the company’s existing focus on craniofacial reconstruction, rhinoplasty, orthopaedic and dental surgery.

The decision to broaden Osteopore’s 3D printing services followed sustained, case-by-case requests from clinicians who were already using the company’s expertise in patient-specific solutions.

For healthcare professionals, this development reflects a practical response to clinical demand rather than a speculative commercial move. Recurrent engagement from surgical teams effectively confirmed the relevance of in-house design and manufacturing capabilities in supporting operative workflows.

The expanded service offering focuses on two clinically oriented applications. First, patient-specific anatomical models are produced to support pre-operative planning. These models enable surgeons to assess complex anatomies in three dimensions, refine their surgical approach, and anticipate potential challenges before entering the operating theatre.

Second, customised cutting guides are developed to align precisely with an individual patient’s anatomy. By translating pre-operative planning into intraoperative accuracy, these guides aim to improve precision, streamline procedural steps, and reduce variability.

From a clinical standpoint, both tools are intended to enhance efficiency and risk management. Ultimately, the objective is to support safer procedures and more predictable patient outcomes.

While several hospitals have established in-house 3D printing units, there is limited evidence of a single solution provider scaling additive manufacturing (AM) services across an entire national healthcare system. This contrast highlights the structural and regulatory barriers that European companies encounter when attempting to deploy AM technologies at scale within healthcare frameworks.

Read more: Business | Current state of public policies that help patients benefit from 3D printed implants

THE 3D ADEPT WEEKLY NEWSLETTER

The industry moves fast. Stay ahead.

Every week, the latest additive manufacturing news, in-depth features and real-world applications, straight to your inbox. Plus, be the first to know when a new issue of 3D ADEPT Mag is out.

Free · One email a week · Unsubscribe anytime

Clicking loads our email provider’s sign-up form, including its analytics and Google’s anti-bot protection. You’re only subscribed if you complete the sign-up. Read our privacy policy.

Open the form in a new tab ↗

Share this article

LinkedInFacebookXWhatsAppE-mail

The weekly newsletter

Essential AM knowledge, delivered weekly.

News, in-depth features and industry perspectives, in your inbox.

Receive the newsletter